News
News-Medical.Net on MSN7h
What’s behind Gen Z’s skepticism about Ozempic and WegovyA U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...
Novo Nordisk’s SOUL trial confirms that oral semaglutide significantly reduces the risk of heart attack, stroke, and ...
GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...
Pharmaceutical Technology on MSN15d
Novo Nordisk outlays $1.09bn to boost GLP-1RA production in BrazilThe Montes Claros site in Brazil is just one of many that Novo Nordisk has poured billions of dollars into as part of efforts ...
Evolus' competitive edge includes a cash-pay model, strong digital marketing and loyalty programs. Click here to find out why ...
Shares of Novo Nordisk, Eli Lilly, Structure Therapeutics and Viking Therapeutics gain as PFE abandons development of its ...
The obsession with being skinny is back and trending on TikTok. Influencers are calling it “SkinnyTok,“ where they promote ...
FDA also cleared a pulse detection feature on a smartwatch and an AI-assisted image analysis app ... In addition, semaglutide (Ozempic, Novo Nordisk) received an expanded indication to reduce ...
Zacks Investment Research on MSN8d
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play itHims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late, which are much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback